Market Tracker

06/27 8:55am ET

Redhill Biopharma Ltd (NASDAQ:RDHL)

10.59
Delayed Data
As of Jun 24
 -0.28 / -2.58%
Today’s Change
8.10
Today|||52-Week Range
20.19
-17.78%
Year-to-Date

Today’s Trading

Previous close10.87
Today’s open10.50
Day’s range10.31 - 10.84
Volume12,483
Average volume (3 months)21,605
Market cap$135.0M
Dividend yield--
Data as of 06/24/2016

Growth & Valuation

Earnings growth (last year)-60.54%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-99.96%
P/E ratio--
Price/Sales47,981.20
Price/Book2.24

Competitors

 Today’s
change
Today’s
% change
ARQLArQule Inc-0.01-0.52%
STMLStemline Therapeutic...-0.11-1.55%
CLSDClearside Biomedical...-0.10-1.45%
CARACara Therapeutics In...-0.23-4.54%
Data as of 06/24/2016

Financials

Next reporting dateJuly 27, 2016
EPS forecast (this quarter)-$0.58
Annual revenue (last year)$3.0K
Annual profit (last year)-$21.1M
Net profit margin-703,000.00%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Dror Ben-Asher
Deputy CEO- Finance &
Operations
Ori Shilo
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts